Trump Signals Openness to Tariff Deals, Eyes Pharmaceutical Industry for Next Trade Action

During a conversation with reporters aboard Air Force One, the president revealed that his administration was preparing to announce new tariffs targeting the pharmaceutical sector. While he refrained from providing specifics on the timing or the tariff rates, the declaration adds a new dimension to the White House’s aggressive trade policy.

Trump Signals Openness to Tariff Deals, Eyes Pharmaceutical Industry for Next Trade Action
News

In a notable shift in his trade stance, US President Donald Trump expressed a willingness to negotiate agreements with countries aiming to sidestep impending reciprocal tariffs. However, Trump emphasized that any such deals would follow the formal implementation of the tariffs on April 2.

During a conversation with reporters aboard Air Force One, the president revealed that his administration was preparing to announce new tariffs targeting the pharmaceutical sector. While he refrained from providing specifics on the timing or the tariff rates, the declaration adds a new dimension to the White House’s aggressive trade policy.

"Countries like Britain have approached us, hoping to strike agreements and avoid these tariffs," Trump said, as reported by Reuters. "I'm open to making deals, but only if we receive something in return."

When asked whether negotiations could be concluded before the tariffs take effect, Trump dismissed the possibility. "No, probably later. It's a process," he remarked.

Focus on US-India Trade Relations

Trump also commented on trade relations with India, highlighting optimism about the progress of discussions. He described Prime Minister Narendra Modi as a "great friend" and praised the recent bilateral talks as constructive.

"India is one of the highest tariffing nations in the world," Trump said. "It's brutal. But Modi is a smart man, and I believe our trade relationship will improve significantly."

The president’s remarks reflect his administration’s broader strategy to address what it perceives as unfair trade practices. By leveraging tariffs as a negotiation tool, Trump aims to secure more favorable trade terms for the US across various sectors, with the pharmaceutical industry now appearing to be his next target.

As the April 2 deadline approaches, all eyes will be on how the administration navigates these critical negotiations and the potential ripple effects on global trade.